Stay updated on Nusinersen Safety in SMA Clinical Trial

Sign up to get notified when there's something new on the Nusinersen Safety in SMA Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nusinersen Safety in SMA Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    - Added new topic: Spinal muscular atrophy and updated to revision v3.2.0. - Removed specific term: Proximal spinal muscular atrophy and previous revision v3.1.0.
    Difference
    2%
    Check dated 2025-10-05T17:39:43.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or update a
    Difference
    0.0%
    Check dated 2025-09-28T11:13:01.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.
    Difference
    0.1%
    Check dated 2025-09-14T00:38:41.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-06T21:29:01.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The web page has updated its facility name and location details, specifically adding 'München, Germany, 80337' and 'nusinersen' while removing references to 'Amyotrophic Lateral Sclerosis' and other related terms.
    Difference
    1%
    Check dated 2025-08-30T15:59:22.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.0%
    Check dated 2025-08-16T12:45:54.000Z thumbnail image

Stay in the know with updates to Nusinersen Safety in SMA Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nusinersen Safety in SMA Clinical Trial page.